Artivion, Inc. (AORT)
Artivion, Inc. (AORT) specializes in the development, manufacturing, and distribution of medical devices and tissue products for cardiovascular and general surgical procedures. The company focuses on providing biologic tissue products used in heart valve replacements, vascular grafts, and other surgical interventions, emphasizing regenerative and preservation techniques.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 18, 2015 | $0.03 | 2015-12-09 | 2015-12-11 |
| September 18, 2015 | $0.03 | 2015-09-09 | 2015-09-11 |
| June 19, 2015 | $0.03 | 2015-06-10 | 2015-06-12 |
| March 20, 2015 | $0.03 | 2015-03-11 | 2015-03-13 |
| December 19, 2014 | $0.03 | 2014-12-10 | 2014-12-12 |
Dividends Summary
- Artivion, Inc. has issued 14 dividend payments over the past 3 years
- The most recent dividend was paid 3598 days ago, on December 18, 2015
- The highest dividend payed out to investors during this period was $0.03 per share
- The average dividend paid during this period was $0.03 per share.
Company News
Artivion Inc, a cardiac and vascular solutions company, has received mixed analyst ratings with an average 12-month price target of $43.83. The company shows strong financial performance with impressive revenue growth, net margin, and efficient asset utilization.
Artivion reported strong Q2 2025 financial results, with non-GAAP EPS of $0.24, exceeding expectations and growing 243% year-over-year. Revenue reached $113.0 million, a 15% increase, and the company raised its full-year 2025 guidance.
Artivion, Inc. experienced a data breach on November 20-21, 2024, where an unauthorized third party accessed network files potentially containing sensitive personal information like Social Security Numbers and driver's license details.
AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.